TBF regimen

DRUG2 trials

Sponsors

First Affiliated Hospital Xi'an Jiaotong University, Peking University People's Hospital

Conditions

Allogeneic Hematopoietic Stem Cell TransplantationCentral Nervous System LeukemiaChronic Myelomonocytic Leukemia (CMML)

Unknown Phase

Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia

First Affiliated Hospital Xi'an Jiaotong UniversityAllogeneic Hematopoietic Stem Cell Transplantation, Central Nervous System Leukemia

Start: 2023-01-15End: 2025-12-31Target: 50Updated: 2022-12-28

Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

RecruitingNCT07588594

Peking University People's HospitalChronic Myelomonocytic Leukemia (CMML)

Start: 2026-02-13End: 2028-05-01Target: 31Updated: 2026-09-15

Related Papers

Mitoxantrone hydrochloride liposome injection combined with thiotepa-busulfan-fludarabine (MTBF) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation for central nervous system leukemia:a single-center retrospective case-control study

Blood2025-11-03